Astrazeneca plc ADR (NASDAQ: AZN) is -1.26% lower on its value in year-to-date trading and has touched a low of $60.47 and a high of $76.56 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AZN stock was last observed hovering at around $66.19 in the last trading session, with the day’s gains setting it 0.31%.
Currently trading at $66.50, the stock is 3.54% and 0.56% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.41 million and changing 0.47% at the moment leaves the stock -1.33% off its SMA200. AZN registered 3.71% gain for a year compared to 6-month loss of -2.21%. The firm has a 50-day simple moving average (SMA 50) of $4.92 and a 200-day simple moving average (SMA200) of $16.78.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -0.08% gain in the last 1 month and extending the period to 3 months gives it a 4.58%, and is 2.94% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.09% over the week and 1.54% over the month.
Astrazeneca plc ADR (AZN) has around 89900 employees, a market worth around $206.18B and $45.81B in sales. Current P/E ratio is 34.84 and Fwd P/E is 14.36. Profit margin for the company is 13.00%. Distance from 52-week low is 9.97% and -13.14% from its 52-week high. The company has generated returns on investments over the last 12 months (9.55%).
Astrazeneca plc ADR quarterly earnings per share for the current quarter are estimated at $1.25 with sales reaching $11.98B over the same period.The EPS is expected to grow by 12.47% this year, but quarterly earnings will post 10.90% year-over-year. Quarterly sales are estimated to grow 13.50% in year-over-year returns.
Astrazeneca plc ADR (AZN) Top Institutional Holders
1,341 institutions hold shares in Astrazeneca plc ADR (AZN), with institutional investors hold 16.80% of the company’s shares. The shares outstanding are 3.10B, and float is at 3.10B with Short Float at 0.29%. Institutions hold 16.80% of the Float.
The top institutional shareholder in the company is Price (T.Rowe) Associates Inc with over 52.85 million shares valued at $3.78 billion. The investor’s holdings represent 2.01% of the AZN Shares outstanding. As of Jun 29, 2023, the second largest holder is Wellington Management Group, LLP with 49.13 million shares valued at $3.52 billion to account for 1.87% of the shares outstanding. The other top investors are Primecap Management Company which holds 44.08 million shares representing 1.68% and valued at over $3.15 billion, while Capital International Investors holds 1.46% of the shares totaling 38.34 million with a market value of $2.74 billion.
